November 3rd, 2011
Sapien Transcatheter Aortic Heart Valve Gains FDA Approval
Larry Husten, PHD
After much anticipation and drama, the FDA has approved the Sapien transcatheter heart valve (THV). The news was announced late Wednesday afternoon by the FDA and by Edwards Lifesciences, the manufacturer of the device. Details about the approval are scarce. The FDA said the Sapien THV has been “approved for patients who are not eligible for […]
NEJM Journal Watch — Recent Cardiology Articles- GLP-1 Agonists and SGLT-2 Inhibitors Together Have Greater Cardiorenal Benefits
- More Data Support Semaglutide for Obesity-Related HFpEF, Regardless of Diabetes Diagnosis
- A Novel Agent Fails to Improve Outcomes in Diabetic Cardiomyopathy
- Persistent Symptoms After Valve Replacement for Severe Aortic Stenosis
- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?